97 related articles for article (PubMed ID: 18318191)
21. [Artificial inhibition of the complement system].
Kozlov LV; Burdelev OO; Bureeva SV; Kaplun AP
Bioorg Khim; 2007; 33(5):485-510. PubMed ID: 18050655
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin binds C1q and activates the classical pathway of complement.
Peake PW; Shen Y; Walther A; Charlesworth JA
Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
[TBL] [Abstract][Full Text] [Related]
23. Iron ions and haeme modulate the binding properties of complement subcomponent C1q and of immunoglobulins.
Dimitrov JD; Roumenina LT; Doltchinkova VR; Vassilev TL
Scand J Immunol; 2007 Mar; 65(3):230-9. PubMed ID: 17309777
[TBL] [Abstract][Full Text] [Related]
24. Anticomplement activity of organic solvent extracts from Korea local Amarantaceae spp.
Jung S; Lee JH; Lee YC; Moon HI
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):210-2. PubMed ID: 21736535
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications.
Perricone C; De Carolis C; Giacomelli R; Greco E; Cipriani P; Ballanti E; Novelli L; Perricone R
Int J Immunopathol Pharmacol; 2011; 24(1):63-8. PubMed ID: 21496388
[TBL] [Abstract][Full Text] [Related]
26. [Inhibition of binding of activated compliment component C4b with its target].
Kozlov LV; Lakhtin VM; Skorokhodova TG; Batalova TN; Shoĭbonov BB; D'iakov VL; Guzova VA; Matveevskaia NS
Bioorg Khim; 2000 Nov; 26(11):817-24. PubMed ID: 11696892
[TBL] [Abstract][Full Text] [Related]
27. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation.
Beinrohr L; Dobó J; Závodszky P; Gál P
Trends Mol Med; 2008 Dec; 14(12):511-21. PubMed ID: 18977695
[TBL] [Abstract][Full Text] [Related]
28. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
[TBL] [Abstract][Full Text] [Related]
29. Relevance of anti-C1q autoantibodies to lupus nephritis.
Tsirogianni A; Pipi E; Soufleros K
Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
[TBL] [Abstract][Full Text] [Related]
30. Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly.
Sjöberg AP; Nyström S; Hammarström P; Blom AM
Mol Immunol; 2008 Jun; 45(11):3213-21. PubMed ID: 18406463
[TBL] [Abstract][Full Text] [Related]
31. Isolation of constituents and anti-complement activity from Acer okamotoanum.
Jin W; Min BS; Lee J; Thuong PT; Lee HK; Song K; Seong YH; Bae K
Arch Pharm Res; 2007 Feb; 30(2):172-6. PubMed ID: 17366738
[TBL] [Abstract][Full Text] [Related]
32. [Anti-complement activity of polysaccharide B3-PS2 purified from Herba Scutellariae Barbatae].
Wu Y; Wei HP; Wang JB
Yao Xue Xue Bao; 2009 Jun; 44(6):615-9. PubMed ID: 19806892
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
34. Mapping the complement C1q binding site in Haemonchus contortus calreticulin.
Naresha S; Suryawanshi A; Agarwal M; Singh BP; Joshi P
Mol Biochem Parasitol; 2009 Jul; 166(1):42-6. PubMed ID: 19428671
[TBL] [Abstract][Full Text] [Related]
35. Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis.
Christadoss P; Tüzün E; Li J; Saini SS; Yang H
Ann N Y Acad Sci; 2008; 1132():210-9. PubMed ID: 18567870
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii.
Xu H; Zhang Y; Zhang J; Chen D
Int Immunopharmacol; 2007 Feb; 7(2):175-82. PubMed ID: 17178384
[TBL] [Abstract][Full Text] [Related]
37. Interaction of human C1q with IgG and IgM: revisited.
Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
[TBL] [Abstract][Full Text] [Related]
38. Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection.
Petry F; Jakobi V; Wagner S; Tessema TS; Thiel S; Loos M
Mol Immunol; 2008 Jul; 45(12):3392-400. PubMed ID: 18501966
[TBL] [Abstract][Full Text] [Related]
39. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways.
Trouw LA; Haisma EM; Levarht EW; van der Woude D; Ioan-Facsinay A; Daha MR; Huizinga TW; Toes RE
Arthritis Rheum; 2009 Jul; 60(7):1923-31. PubMed ID: 19565507
[TBL] [Abstract][Full Text] [Related]
40. Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system.
Manderson GA; Martin M; Onnerfjord P; Saxne T; Schmidtchen A; Mollnes TE; Heinegård D; Blom AM
Mol Immunol; 2009 Oct; 46(16):3388-98. PubMed ID: 19674792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
